RI
BEAM icon

RTW Investments’s Beam Therapeutics BEAM Stock Holding History

RTW Investments’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.6M Hold
570,394
– – 0.14% 65
2025
Q4 		$15.8M Buy
+570,394
New +$14.6M 0.16% 64
2025
Q2 		– Sell
-438,659
Closed -$8.57M – 75
2025
Q1 		$8.57M Buy
+438,659
New +$11.5M 0.13% 55

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

RTW Investments's BEAM Position: Q1 2026 in Review

RTW Investments held its Beam Therapeutics (BEAM) position steady in Q1 2026 at 570,394 shares worth $13.6M. The position accounts for 0.14% of the portfolio, ranked #65.

RTW Investments first reported a position in BEAM in Q1 2025 and has held it in 3 quarters since. The position peaked at $15.8M in Q4 2025. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

  • RTW Investments held 570,394 shares of Beam Therapeutics worth $13.6M as of Q1 2026.
  • RTW Investments left its Beam Therapeutics share count unchanged in Q1 2026.
  • Beam Therapeutics made up 0.14% of RTW Investments's portfolio in Q1 2026, its #65 holding.
  • RTW Investments first reported a position in Beam Therapeutics in Q1 2025 and has held it in 3 quarters since.
  • RTW Investments's Beam Therapeutics position peaked at $15.8M in Q4 2025.
  • 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on RTW Investments's 13F filing for Q1 2026, filed 15 May 2026.